Beatriz Gros Profile Banner
Beatriz Gros Profile
Beatriz Gros

@Bealoquebea

Followers
5,416
Following
857
Media
850
Statuses
9,864

Gastroenterologist #IBD specialist at @hureinasofia @IMIBIC Help others grow their abilities and celebrate life. IBD education at

Edinburgh, Scotland
Joined August 2011
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@Bealoquebea
Beatriz Gros
7 months
🌟Ever found yourself doubting about IBD new drugs doses? or forgetting Thiopurine metabolism details? I've been there too So I thought it could help having "IBD Cheat Sheets" and that is what I did: I hope it helps as much as it helps me 1/2 #IBD
Tweet media one
31
125
347
@Bealoquebea
Beatriz Gros
2 years
Many of you know I love timelines & I have been updating the one on IBD trials/studies for some time🧵 The landscape is changing fast & there isnt enough space here to share all the content As such I have created a website to collect it all and to make it interactive
Tweet media one
Tweet media two
Tweet media three
Tweet media four
50
160
448
@Bealoquebea
Beatriz Gros
1 year
Has it ever been difficult for you to find the latest guidelines or consensus on IBD from different societies? Not anymore ⭐️New section “guidelines” in And tomorrow newsletter with a new evidence corner and new trials added 🤩
26
120
338
@Bealoquebea
Beatriz Gros
3 years
After my previous summary of IBD studies,I finished yesterday this timeline which is more visual. I hope it can be useful to see where we come from and where we go. There may be some mistakes,but please I did it with my best intention, same with missing studies.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
36
76
321
@Bealoquebea
Beatriz Gros
1 year
IBD classifications,scores and indices are something we often use and I thought having the most used ones all together could be helpful ⭐️New section Suggestions are welcome 🙏🏻
Tweet media one
7
99
284
@Bealoquebea
Beatriz Gros
4 months
Someone reached out suggesting I compile a summary of #IBD H2H trials His suggestion motivated me to complete the one I had 🌟So, here it is over 35 trials. Hope it proves helpful! You'll have to access the website to view it in full. Happy to add
Tweet media one
20
81
274
@Bealoquebea
Beatriz Gros
3 months
My website made it to the US 🤩 This is like a dream although I have to admit my biggest followers come from 🇺🇸 with >45K visits within 15 months @DDWMeeting #DDW2024
Tweet media one
26
39
269
@Bealoquebea
Beatriz Gros
2 years
I don’t share much of my personal life on twitter but this day was absolutely worth it. @fjseruf and I finally married. Living in 2 different countries for 18 months has not stopped us!!
Tweet media one
76
7
269
@Bealoquebea
Beatriz Gros
1 year
⭐️Exciting news! Our ulcerative colitis review published in @JAMANetwork @JAMA_current A massive shoutout to the brilliant @gilkaplan and fantastic support from @lasser_karen This project has been a work of passion& meaningful networking #UC 1/2
19
59
219
@Bealoquebea
Beatriz Gros
6 months
Years ago, I shared the first #IBD timeline here w the names of relevant studies With the advent of the web, updates of those slides paused ⭐️at #ECCO2024 I noticed it could still be useful. I did an updated version (incl 2024!) Hope it helps! Happy to add/change anything
Tweet media one
11
48
218
@Bealoquebea
Beatriz Gros
1 month
The IBD landscape is getting intense with so many exciting trials! 📈 #IBD cheatsheets just updated in light of recent publications 😃
Tweet media one
8
53
210
@Bealoquebea
Beatriz Gros
9 months
🌟 November-Exciting News IBD-EII! 🌟 🧵 🆕 Introducing the new "IBD multifactorial" section at Delve into the risk & protective factors that have been associated with IBD onset. Over 190 studies organized per year and type of factor!
Tweet media one
11
78
206
@Bealoquebea
Beatriz Gros
8 months
1/ In my 'Back to basics' in #IBD , today I delve into the tumor necrosis factor #TNF history 🧵Let's talk about TNF-alfa, one of the most well-known cytokines in IBD from discovery to present-day applications It's discovery is fascinating
Tweet media one
6
61
192
@Bealoquebea
Beatriz Gros
5 months
JAK-STAT pathways can be complex to understand, gaining insight into their functions helps us comprehend the consequences of their blockade. Bearing this in mind, I have done a summary attempting to synthesize this complexity focusing on #IBD therapies, I hope it proves useful.
Tweet media one
11
44
187
@Bealoquebea
Beatriz Gros
2 years
I have been working on this project for months. A website constantly being updated with summaries of all the important studies in IBD. At the moment over 140 studies.
Tweet media one
13
54
184
@Bealoquebea
Beatriz Gros
8 months
1/ I've read the TACOS trial on the use of tofacitinib in acute severe #UC I'll break down some important highlights &/or reflections which I found of interest (In any case, I recommend reading the full study) 🔎Important tweets are number 7 & 8
Tweet media one
7
48
176
@Bealoquebea
Beatriz Gros
1 month
Mom would have turned 65 today. She passed 9 years ago Devoted to work and science Fierce love for family and life Always radiated joy All these years taken from us. Life is short and fragile; we are remembered for the love we give. 🤍🤍
Tweet media one
20
6
171
@Bealoquebea
Beatriz Gros
2 years
When Attending to congresses I recommend keeping this in mind & being extremely polite and grateful to the person who has presented. The effort of preparing the talk plus the pressure of talking in front of others should be taken into account. #UEGWeek #UEGWeek22 @my_ueg
Tweet media one
6
45
162
@Bealoquebea
Beatriz Gros
2 years
Multiple successive switches from IFX originator to biosimilars are effective and safe in patients with IBD, irrespective of the number of IFX switches. 🧵 Our paper is open for you to read.
Tweet media one
7
40
156
@Bealoquebea
Beatriz Gros
7 months
Celebrating one year since I launched In a year I collected >950 studies with >220k visits & >20k downloads Huge thanks to everyone who supported along the way! 🙌 “In a gentle way, you can always shake the world”
@Bealoquebea
Beatriz Gros
2 years
Many of you know I love timelines & I have been updating the one on IBD trials/studies for some time🧵 The landscape is changing fast & there isnt enough space here to share all the content As such I have created a website to collect it all and to make it interactive
Tweet media one
Tweet media two
Tweet media three
Tweet media four
50
160
448
23
20
159
@Bealoquebea
Beatriz Gros
8 months
As many are sharing their top 2023 articles, remember on you'll find the most important RCTs & many other 2023 relevant studies This has been an exciting adventure that I never thought would go this far in less than a year Thanks for all the support
Tweet media one
9
33
153
@Bealoquebea
Beatriz Gros
10 months
In my 'back to basics' in #IBD , I delve into the world of biomarkers 🧵Let's talk about the interesting C-reactive protein #CRP 📖 Discovery dates back to 1930 by Tillett & Francis (Rockefeller institute for Medical Research 🇺🇸) ⬇️
3
46
152
@Bealoquebea
Beatriz Gros
3 years
I summarize many concepts for my residents and myself. I did one of important studies in IBD ordered by year.Some suggested that I share it,as it may be useful to other people. There may be some mistakes but,did it with my best intention.I know some info is left but cannot extend
Tweet media one
Tweet media two
Tweet media three
Tweet media four
17
40
148
@Bealoquebea
Beatriz Gros
1 year
For those who inquired about its authorship, these are the IBD timeline graphs I created! Feel free to use it if it benefits you! 📎Attached are both the complete version in a single slide and the separated version for your convenience. #IBD #MedEd
Tweet media one
9
33
139
@Bealoquebea
Beatriz Gros
7 months
I grew up surrounded by science; my mum was a researcher throughout her life & dedicated herself entirely to it In her memory & in honor of all women striving to carve out a place in a world that isn't always fair & equal for them 📷:mum giving me my MD title #WomenInScience
Tweet media one
16
6
136
@Bealoquebea
Beatriz Gros
2 months
Just saw this and needed to share A @lego character with her #ostomy This really made my day, more and more representation of this to normalize the large number of patients living with a stoma 🤩🤩
Tweet media one
4
30
136
@Bealoquebea
Beatriz Gros
1 year
Ileocaecal resection in newly diagnosed CD associated to improved long-term outcomes compared to TNFinh very nice presentation @ManasiAgrawalMD #IBD #ecco2023 More data supporting the LIR!C trial
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
42
135
@Bealoquebea
Beatriz Gros
6 months
At this #ECCO2024 , I'm presenting my first poster from ⭐️This project became a reality thanks to everyone who supported it Despite navigating the challenges w limited experience on websites,my passion propels this endeavor &I'm eager to share it with you
Tweet media one
12
29
135
@Bealoquebea
Beatriz Gros
2 months
Ever wondered how TNF inh work in #IBD ? Curious about the emerging TL1A inhibitors on the horizon? 🌟I've tackled these questions & created a comprehensive summary Full-quality image at More content coming this weekend! Subscribe for free to stay
Tweet media one
3
38
132
@Bealoquebea
Beatriz Gros
6 months
Is there anything that I may have missed from the pre biologic/small molecule/immunesupressant screening? It has been something that some of you asked me to add to Please feel free to improve this summary, I really appreciate your help
Tweet media one
25
35
131
@Bealoquebea
Beatriz Gros
2 years
I’m still processing that I will be presenting at #DDWMeeting @AmerGastroAssn Big thanks to @charlie_lees & @LauranneDerikx for your amazing support&mentoring over this almost 2 wouldnt have been possible without you.Also to rest of authors🙏🏻 #hereforDDW
Tweet media one
17
8
124
@Bealoquebea
Beatriz Gros
3 months
Positioning #IBD therapies greatly presented by @IBDMD at #DDW2024 @DDWMeeting
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
32
120
@Bealoquebea
Beatriz Gros
8 months
Still, I am at a loss for words to describe how difficult It feels to leave Thanks to everyone at WGH, you are really incredible Charlie, thanks for trusting in my abilities & reminding me of all that I am capable of doing I will always be indebted.Our friendship means a lot 🙏🏻
@charlie_lees
Charlie Lees
8 months
After 2.5 years, today is Bea's last official day working in the Edinburgh IBD Unit. It is difficult to express here what an incredible impact she has made on the entire team in Edinburgh. Her hard work, dedication, passion and joy for the every day has impacted us all and
Tweet media one
10
11
208
5
6
116
@Bealoquebea
Beatriz Gros
6 months
Data from PROFILE trial Amazing presentation by Nuru Noor Top down IFX+IMM from diagnosis of #CD shows: -⬆️sustained steroid & surgery-free remission -No increase in serious infections -67% endoscopic remission rate and 10x ⬇️in urgent abdominal surgery #ECCO2024 #ECCO24
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
36
116
@Bealoquebea
Beatriz Gros
7 months
Coconut water in mild-mod UC vs placebo (both arms+standard therapy) 🌟 response 57.1% vs 28.3%, p=0.014 🌟 remission 53.1% vs 28.3%, p=0.02 FC & 🦠 changes but not endoscopy w8 @ShomronH & @RichardPollok will enjoy this reading, 🤔 outside 📦 .
6
28
111
@Bealoquebea
Beatriz Gros
2 years
Thank you very much @Iagorlago and @Iris_Dotan for this prize. I feel so grateful, this would have never been possible without @charlie_lees @LauranneDerikx @PlevrisN @IBDNathan @Gastro_GRJ
Tweet media one
Tweet media two
22
7
110
@Bealoquebea
Beatriz Gros
1 year
🎉 Exciting news! My website has hit an incredible milestone over- 100,000 visits in just 6 months! ✨It's a testament to the power of passion and determination. 💪 #ChaseYourDreams #PassionProjects #IBD
14
11
111
@Bealoquebea
Beatriz Gros
3 years
🇪🇸🇬🇧Voy a escribir una línea de tuits para explicar por si le sirve a alguien cómo proceder para trabajar de médico en UK contando con los cambios del Brexit. Lo cuento según lo que he tenido que hacer,puede que haya más opciones. Si alguien necesita ayuda no dude en contactarme.
19
25
108
@Bealoquebea
Beatriz Gros
28 days
🌟When you dream big, the sky's the limit! This month marks 18 months since was created, since then: - I have summarized >415 clinical trial & much more - Received >300K+ visits (from 152 countries) - 1290 subscriptions - 34,700 content downloads
Tweet media one
7
9
110
@Bealoquebea
Beatriz Gros
5 months
The impact of the adherence to Mediterranean diet and physical activity on #IBD prognosis ⭐️Healthy lifestyle was associated with: - Lower risk of mod-severe relapses (aHR, 0.250; 0.093-0.670) - Steroids use (aHR 0.292; 0.103-0.828) - Lower risk of mod-severe relapses (aHR
Tweet media one
1
34
107
@Bealoquebea
Beatriz Gros
5 months
My younger sister Monica Gros defended her thesis today, the result of great effort and passion ☀️She works as a mountain rescue doctor, and yet she managed to complete her doctoral thesis in her spare time for free (like almost all doctors in Spain) on IBS and the intestinal
Tweet media one
10
3
107
@Bealoquebea
Beatriz Gros
21 days
Understanding how drugs work, helps us understand their full potential & adverse effects 🌟In today's back to basics, how do the immunosuppressants used in #IBD & other diseases work? Starting from the intriguing function of methotrexate, efficacious in #CD to maintain
Tweet media one
3
27
102
@Bealoquebea
Beatriz Gros
6 months
A number of relevant changes have been made to the new #CD ECCO guideline to be published in JCC ✅new drugs ✅language change no “conventional” therapy but “evidence based” ✅downgrading some old therapy ✅role of EEN And much more! Cannot wait to read it 🤩 Great job @IBD_MB
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
27
100
@Bealoquebea
Beatriz Gros
3 months
Adherence to mediterranean diet in newly diagnosed #CD was associated with ⬇️ levels of primary bile acids ⬇️microbial disbiosis ✅ non-complicated CD course #DDW2024 @LGodny congrats
Tweet media one
Tweet media two
5
30
100
@Bealoquebea
Beatriz Gros
11 months
Excited to unveil the latest additions! Check out the updated timeline Feel free to use it if it helps you 😊 Explore this and much more in #IBD #MedEd
Tweet media one
2
24
100
@Bealoquebea
Beatriz Gros
6 months
The rational of advanced combination therapy in #IBD @bruce_sands1 presenting a great overview of the past and future of these combinations at #ECCO2024 #ECCO24
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
22
98
@Bealoquebea
Beatriz Gros
1 year
Ileocaecal surgery for new CD is associated with improved long-term outcomes compared to AntiTNF nicely presented by @ManasiAgrawalMD at #DDW2023 #AGALIVE #IBD
Tweet media one
Tweet media two
Tweet media three
4
25
96
@Bealoquebea
Beatriz Gros
4 months
People often ask me how I manage to tweet so quickly during congresses Here's the trick!!!: I prep every session beforehand. 🌟 I compile a Word doc with titles, dates/rooms, and abstracts, which I print and take along for note-taking. Why? 1⃣ Gain insight before the talk 2⃣
Tweet media one
3
8
94
@Bealoquebea
Beatriz Gros
9 months
🔬 Our latest real-world cohort study unveils exciting insights into Filgotinib's impact on ulcerative colitis treatment. First real-world evidence published. #UlcerativeColitis #Filgotinib #UC 1/4
Tweet media one
2
27
93
@Bealoquebea
Beatriz Gros
3 months
Perianal and intra abdominal fistulizing #CD management ✅team with the surgeons ❌antibiotics alone ✅antiTNF ❓other drugs Great overview by @MRegueiroMD at @DDWMeeting #DDW2024
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
29
92
@Bealoquebea
Beatriz Gros
2 years
3rd update of the timeline of IBD trials & studies. Thanks to all of you writing to remind me the missing ones. Team work 🤩 More than 120 studies. Doing this has been so helpful to organize my knowledge,hope this can help others.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
8
23
89
@Bealoquebea
Beatriz Gros
6 months
Do not miss our work about authorship gender representation of #IBD trials from 1955-2023 You will find it at #ECCO2024 poster presentation number 791 ⭐️this work has been possible thanks to @JosephHabibi_MD @BassiMehak @DCharabaty
Tweet media one
4
21
88
@Bealoquebea
Beatriz Gros
5 months
This month in new additions! ⭐️ 12 new summaries in the timeline ⭐️ New cheat sheets and much more!! If you don't want to miss any of these you can subscribe for free If you don't enjoy it you can cancel anytime, we will miss you but this will allow
Tweet media one
1
21
85
@Bealoquebea
Beatriz Gros
1 year
Kono-S anastomosis associated to ⬇️ risk of postop recurrence in CD. Disease extension >50cm associated to ⬆️ recurrence. The SUPREME-CD trial presented by Gaetano Luglio at #DDW2023 #AGALIVE2023 @DDWMeeting @geteccu
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
31
87
@Bealoquebea
Beatriz Gros
3 months
“Bea why do you tweet everything at conferences?” ⭐️there are many reasons, like benefiting those who cannot attend BUT one is purely for my own benefit Using twitter as a diary!! It helps me easily find & review data, prepare talks… 📹Here a video of an example Hope it
3
4
87
@Bealoquebea
Beatriz Gros
1 year
Monitoring calprotectine in IBD using a sweat wearable device. Amazing future to come #DDW2023 #AgaLive2023 @geteccu @DDWMeeting
Tweet media one
Tweet media two
Tweet media three
Tweet media four
6
20
86
@Bealoquebea
Beatriz Gros
3 months
TDM in #IBD , when it refers at least to antiTNF there should be little to no debate on this topic at this stage but for some reason still is 🧐 Great summary from Adam Cheifetz At @DDWMeeting #DDW2024
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
27
84
@Bealoquebea
Beatriz Gros
1 year
Outstanding opening talk about sequencing therapy in #CD at #ecco2023 by @IBDMD #IBD
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
20
82
@Bealoquebea
Beatriz Gros
1 year
Such an outstanding talk by @charlie_lees as always. Fascinating to finally see the @predicct study data at #DDW2023 #AGALIVE2023 @DDWMeeting
Tweet media one
Tweet media two
Tweet media three
Tweet media four
8
18
81
@Bealoquebea
Beatriz Gros
9 months
Speechless seeing the impact of the latest post on the website! Over 23k visits in 4 days, now soaring past 180k in under 10 months. Grateful for the trust in my work—this support only fuels my drive to keep pushing boundaries. Thank you all!
Tweet media one
@Bealoquebea
Beatriz Gros
9 months
🌟 November-Exciting News IBD-EII! 🌟 🧵 🆕 Introducing the new "IBD multifactorial" section at Delve into the risk & protective factors that have been associated with IBD onset. Over 190 studies organized per year and type of factor!
Tweet media one
11
78
206
7
7
82
@Bealoquebea
Beatriz Gros
1 month
SEQUENCE in detail (RIS vs UST in #CD ) Summary: RIS non inferior to UST in clinical rem w24 & RIS superior UST in endoscopic rem w48 Some relevant details for me: 1⃣Open label- patients & clinicians knew drug assignment (central reader blinded) this differs from VIVID (MIRI vs
Tweet media one
5
26
82
@Bealoquebea
Beatriz Gros
1 year
Ileocaecal resection may have a role as first-line therapy in #CD , findings supporting the results from the LIR!C trial 🤩 Congratulations @ManasiAgrawalMD @JeanFredericCo1 @ryanungaro @DrTineJess and rest of authors
1
21
81
@Bealoquebea
Beatriz Gros
1 month
Happy to share my views on how social media has become an indispensable tool for disseminating health information at @my_ueg
6
16
79
@Bealoquebea
Beatriz Gros
6 months
Personalized therapy in #IBD Greatly Presented by @SeverineVermei1 at #ECCO2024 #ECCO24
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
15
79
@Bealoquebea
Beatriz Gros
7 months
🤔Ever found yourself thinking, 'Should I prescribe this drug for my IBD patient that will also treat his/her other IMID? Are you aware of which drugs are approved for which indications? It certainly confuses me🫣 Just until now,
Tweet media one
4
20
78
@Bealoquebea
Beatriz Gros
2 years
Muchísimas gracias a @saludigestivo y a la @sepdigestiva por este premio. Me siento muy afortunada. Y más compartiendo este rato con @mjgarciadig también premiada🤩
Tweet media one
Tweet media two
9
12
78
@Bealoquebea
Beatriz Gros
1 year
This #ecco2023 has been great to learn, to share experiences, to see colleagues and friends again. Cannot express enough how wonderful has been to meet again.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
9
77
@Bealoquebea
Beatriz Gros
1 year
Subscribed to ? 📩 Get ready for a captivating month! Check the 'back to basics' in CD From pioneering AZA and steroid trials to the first cA2 (infliximab) experience Uncover these timeless, golden treasures. Don't miss out! #IBD ⬇️👀new timeline slides
Tweet media one
Tweet media two
4
18
76
@Bealoquebea
Beatriz Gros
10 months
Some of the fantastic things of international congresses is getting to know outstanding people at @my_ueg I had the pleasure to meet @ebtapper worldwide known for his passion on hepatology education. The liver meets the gut 😊 #SoMe #MedEd #uegweek23 #UEGweek
Tweet media one
1
2
72
@Bealoquebea
Beatriz Gros
1 year
Managing and understanding perianal fistulas in CD very nicely presented by @HolubarStefan at #DDW2023 #AGALIVE2023 @DDWMeeting
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
27
72
@Bealoquebea
Beatriz Gros
1 year
The role of the appendix in #IBD is intriguing. ⬆️ the risk of CD ⬇️ the risk of UC & clinical course may be milder ‼️This new study presents relevant data regarding possible relationship between appendicectomy & advanced colorectal neoplasia in #UC
3
20
72
@Bealoquebea
Beatriz Gros
10 months
Upadacitinib efficacy and safety in #CD , final results from the phase 3 trial U-ENDURE Presented by Julian Panés at #UEGWeek
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
15
71
@Bealoquebea
Beatriz Gros
2 months
Congratulations! Fantastic update 🤩 Relevant changes from 2019 ✅do not stop biologicals prior surgery (2019 was conditional) ❌no fibrin glue for perianal ✅IFX & ADA for perianal ❓VEDO, UST, RIS, UPA in perianal And much more relevant data! Definitely 👍
@JCC_IBD
Journal of Crohn's and Colitis
2 months
Hot off the press : the #ECCO 2024 #Guidelines on Therapeutics in #CD : Medical Treatment. Excellently lead by Hannah Gordon and @IBD_MB , in close collaboration with ECCO GuiCom, @efcca and many clinicians globally. @Y_ECCO_IBD
Tweet media one
3
98
160
6
24
72
@Bealoquebea
Beatriz Gros
3 months
VIVID-1 h2h trial with mirikizumab vs ustekinumab in #CD ✅mirikizumab achieved non-inferiority to ustekinumab ❗️Be aware this is not like SEQUENCE! Patients here were around 50% previously exposed to AntiTNF whereas SEQUENCE all were previously exposed and the trial design
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
27
71
@Bealoquebea
Beatriz Gros
2 years
The importance of dietician help to manage patients with IBD not only during active disease but also to reduce functional associated symptoms when they are in remission presented by Lauren Manning #UEGWeek #UEGWeek22 @my_ueg
Tweet media one
Tweet media two
Tweet media three
1
18
71
@Bealoquebea
Beatriz Gros
3 months
Monthly update on ⭐️New IBD cheatsheet focusing on anti-IL12/23- including the dual action of guselkumab observed in vitro* ⭐️ 8 new summaries on the timeline, new guides, and studies on multifactorial #IBD and much more!! Don't miss out—subscribe for
Tweet media one
0
25
70
@Bealoquebea
Beatriz Gros
2 years
Mistakes in surveillance in IBD presented by @Rutter_Matt very clear and useful presentation #UEGWeek22 #UEGweek @my_ueg
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
25
70
@Bealoquebea
Beatriz Gros
15 days
FC levels show varying correlations with inflammation depending on the specific bowel segment that is affected Patients with #CD assessed by VCE Very useful to have these cutoffs ✅ proximal SB FC>=77 ✅distal SB FC >= 123 ✅ colonic FC>=291 Congratulations, this is a very
@ShomronH
Shomron Ben-Horin
15 days
FCP is better for colonic > small bowel (SB) inflammatiin, but how accurate is it in proximal vs. distal SB? Using VCE as gold standard, our @sheba_medical brilliant fellow @OffirU reports in @JCC_IBD a dilutional gradient of calpro along the SB !
Tweet media one
5
45
100
2
19
68
@Bealoquebea
Beatriz Gros
7 months
Mi hermana es médico de rescate en el helicóptero que cubre el Pirineo Aragonés Es una de las personas mas increíbles que he conocido y valiente como nadie Este domingo sale en RTVE en un programa en el que muestran lo que hacen ella y su equipo 🤍
Tweet media one
6
5
68
@Bealoquebea
Beatriz Gros
6 months
High definition white light endoscopy with segmental re-inspection 🔦 is non-inferior than dye-based chromoendoscopy in #IBD the HELIOS trial Great talk by Marteen te Groen ar #ECCO2024 #ECCO24
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
16
65
@Bealoquebea
Beatriz Gros
6 months
We lack data on proctitis in clinical trials, and information regarding whether left-sided colitis and extensive colitis respond differently is scarce. ⭐️This study provides valuable insights regarding tofacitinib response depending on disease extension
Tweet media one
3
13
66
@Bealoquebea
Beatriz Gros
10 months
🌟Exciting news! This month, I've been dedicated to enhancing the "Evidence Corner" on , based on your feedback. I've refreshed the "type of drug" section with the latest insights. 1/4
Tweet media one
6
15
65
@Bealoquebea
Beatriz Gros
1 year
Results from the TORUS study: TOFA vs UST in antiTNF exposed UC patients #DDW2023 #AGALIVE presented by Anthony Buisson #IBD
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
15
66
@Bealoquebea
Beatriz Gros
2 years
Today is ostomy awareness day. I am going to share some interesting data that some of you may know. I hope this will help to raise awareness about this situation which is a life saver for many patients.
Tweet media one
2
29
65
@Bealoquebea
Beatriz Gros
25 days
Our study at @TAGastroenterol Long-term outcomes & predictors of vedolizumab persistence in #UC ✅ persistence exceeding 80% at 1y and 50% at 5y 🌟 previous exposure to biologics/small molecules, disease distribution & steroid at baseline influenced persistence ✅ no new
Tweet media one
3
19
65
@Bealoquebea
Beatriz Gros
2 years
Outstanding lecture @JoanaTo62523004 going through the evidence to support the superiority of TNFinh in CD ✅perianal disease ✅EIMS ✅long term safety data (including pregnancy) ✅also cheap (Difficult to choose 4 slides as there were super) @my_ueg #UEGWeek #uegweek22 #IBD
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
21
64
@Bealoquebea
Beatriz Gros
2 years
I am writing a post about Ramadan fasting and IBD.I am astonished there is only 1 study in pubmed published in 2008 which analyzed this. The recommendations I found have sense but are expert opinions. Now it is Ramadan&we have many muslims patients,appropriate info is needed.
5
8
61
@Bealoquebea
Beatriz Gros
1 year
Today starts Ramadan Little reminder that we have little knowledge of the impact of this period on IBD course&recommendations are based on poor quality data 🤔taking into account it is 1 month/y & the amount of muslims in the🌍this is not admissible
5
12
62
@Bealoquebea
Beatriz Gros
6 months
Family planning, pregnancy and lactation Great review at #ECCO2024 #ECCO24 @JulsgaardMette and Irit Avni Biron
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
18
62
@Bealoquebea
Beatriz Gros
22 days
I feel deeply honored to be in this list together with these amazing people Thank you in advance if you vote for me to be awarded 🙏🏻🙏🏻
@HealioGastro
Healio Gastroenterology
22 days
🤳First up: Our nominees for the #HealioInnovators Social Media Influencer are: @DrBloodandGuts @john_damianosMD @Bealoquebea @drpal_manickam @GutsyGirlMD @DrShambayati You’re the judges! Vote here:
3
12
34
6
13
62
@Bealoquebea
Beatriz Gros
2 years
Flying back home, therefore I stop my retransmission of the #UEGWeek22 highlights. It’s been a pleasure to see so many of you interacting with me and valuing my tweets. See you at the ECCO 😊
6
2
62
@Bealoquebea
Beatriz Gros
1 year
LUCENT-1 and LUCENT-2 trials published!! 🌟mirikizumab (anti IL23) 🔎induction 300mg IV vs placebo clinical remission w8 (24.2 vs 13.3, p<0.001) 🔎maintenance 200mg SC clinical remission w40 (49.9% vs 25.1%, p<0.001)
3
18
61
@Bealoquebea
Beatriz Gros
2 years
We know Helicobacter Pylori is a group 1 carcinogen due to its link to gastric cancer. But what about other solid malignancies? What about other Helicobacter species? Our latest publication in Cancers tries to shed a little bit of light in this regards ⬇️⬇️⬇️
5
13
62
@Bealoquebea
Beatriz Gros
3 months
Life is so much richer when you're surrounded by people who inspire you to be better, do more, and reach for your dreams. I'm so lucky to have found a group of friends who not only support me but also challenge me to grow @DCharabaty @JosephHabibi_MD @LumirKunovsky #DDW2024
Tweet media one
1
2
61
@Bealoquebea
Beatriz Gros
1 year
Gaining perspective is not always easy but necessary In #IBD a major source are Cochrane reviews ⭐️A new section is available as “IBD library” with all the IBDCochrane reviews for now (60 in total) Some surprised me when I first read them🤩guess which
Tweet media one
0
19
61
@Bealoquebea
Beatriz Gros
1 year
Today 9/4/23 it's just 2 months since the website was launched I wanted to share some reflections and more importantly to 🙏thank you all🙏 for your appreciation and kind words plus the help that some of you gave me by reminding me missing studies 🧵
4
5
60
@Bealoquebea
Beatriz Gros
7 months
Inverse association between legume intake & colorectal cancer risk Compared to no consumption: - OR for at least 1 portion of legumes 0.79 (0.68-0.91) -OR for 2 or > 0.68 (0.57-0.82) & estimate for an increment of 1 portion per week 0.87 (0.81-0.93)
Tweet media one
2
18
60